196 related articles for article (PubMed ID: 24129196)
21. Diagnostic performance of guaiac-based fecal occult blood test in routine screening: state-wide analysis from Bavaria, Germany.
Brenner H; Hoffmeister M; Birkner B; Stock C
Am J Gastroenterol; 2014 Mar; 109(3):427-35. PubMed ID: 24343548
[TBL] [Abstract][Full Text] [Related]
22. [Colorectal cancer screening: evidence and implementation].
Brenner H; Hoffmeister M
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Mar; 57(3):302-6. PubMed ID: 24562704
[TBL] [Abstract][Full Text] [Related]
23. [Effectiveness of screening colonoscopy in a community-based study].
Hüppe D; Hartmann H; Felten G; Kemen M; Tannapfel A; Gillessen A; Katalinic A
Z Gastroenterol; 2008 Feb; 46(2):193-200. PubMed ID: 18253898
[TBL] [Abstract][Full Text] [Related]
24. Prevention, early detection, and overdiagnosis of colorectal cancer within 10 years of screening colonoscopy in Germany.
Brenner H; Altenhofen L; Stock C; Hoffmeister M
Clin Gastroenterol Hepatol; 2015 Apr; 13(4):717-23. PubMed ID: 25218160
[TBL] [Abstract][Full Text] [Related]
25. [Early detection of bowel cancer in occupational surveillance examinations: switching from a guaiak-based to an immunochemical fecal occult blood test].
Webendörfer S; Riemann JF
Dtsch Med Wochenschr; 2014 Jan; 139(3):79-83. PubMed ID: 24089288
[TBL] [Abstract][Full Text] [Related]
26. Evidence for colorectal cancer screening.
Bretthauer M
Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):417-25. PubMed ID: 20833346
[TBL] [Abstract][Full Text] [Related]
27. Colorectal cancer screening.
Suchánek Š; Grega T; Zavoral M
Vnitr Lek; 2018; 64(6):679-683. PubMed ID: 30223667
[TBL] [Abstract][Full Text] [Related]
28. [Prevention and early detection of colorectal cancer in average risk population--summary of a meeting and the Israeli gastroenterology policy].
Strul H; Elyakim R; Halpern Z; Arber N
Harefuah; 2003 Mar; 142(3):223-6, 236. PubMed ID: 12696479
[TBL] [Abstract][Full Text] [Related]
29. Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up.
Scholefield JH; Moss SM; Mangham CM; Whynes DK; Hardcastle JD
Gut; 2012 Jul; 61(7):1036-40. PubMed ID: 22052062
[TBL] [Abstract][Full Text] [Related]
30. Outpatient colonoscopy complications in the CDC's Colorectal Cancer Screening Demonstration Program: a prospective analysis.
Castro G; Azrak MF; Seeff LC; Royalty J
Cancer; 2013 Aug; 119 Suppl 15():2849-54. PubMed ID: 23868479
[TBL] [Abstract][Full Text] [Related]
31. Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on immunochemical fecal occult blood test in northern Italy.
Parente F; Boemo C; Ardizzoia A; Costa M; Carzaniga P; Ilardo A; Moretti R; Cremaschini M; Parente EM; Pirola ME
Endoscopy; 2013; 45(1):27-34. PubMed ID: 23254404
[TBL] [Abstract][Full Text] [Related]
32. Excellent performance of Hemoccult Sensa in organised colorectal cancer screening.
Kershenbaum A; Flugelman A; Lejbkowicz F; Arad H; Rennert G
Eur J Cancer; 2013 Mar; 49(4):923-30. PubMed ID: 23099005
[TBL] [Abstract][Full Text] [Related]
33. Survival of patients diagnosed with colorectal cancer through a television-advertised screening program.
Slusser SO; Liberski SM; McGarrity TJ
Am J Gastroenterol; 1996 Aug; 91(8):1563-6. PubMed ID: 8759662
[TBL] [Abstract][Full Text] [Related]
34. [Lesions detected in a colorectal cancer screening program in the Basque Country: first round (2009-2011)].
Portillo I; Idígoras I; Ojembarrena E; Arana E; Luis Hurtado J; Basurko R; Tapia M; Luz Peña M
Gastroenterol Hepatol; 2013 May; 36(5):301-8. PubMed ID: 23618538
[TBL] [Abstract][Full Text] [Related]
35. Measuring the quality of colorectal cancer screening: the importance of follow-up.
Etzioni DA; Yano EM; Rubenstein LV; Lee ML; Ko CY; Brook RH; Parkerton PH; Asch SM
Dis Colon Rectum; 2006 Jul; 49(7):1002-10. PubMed ID: 16673056
[TBL] [Abstract][Full Text] [Related]
36. The first 2 years of colorectal cancer screening in Ferrara, Italy.
Matarese VG; Feo CV; Lanza G; Fusetti N; Carpanelli MC; Cataldo S; Cifalà V; Ferretti S; Gafà R; Marzola M; Montanari E; Palmonari C; Simone L; Trevisani L; Stockbrugger R; Gullini S
Eur J Cancer Prev; 2011 May; 20(3):166-8. PubMed ID: 21445018
[TBL] [Abstract][Full Text] [Related]
37. [Epidemiology of screening-targeted cancers according to new data of the Czech National Cancer Registry].
Dušek L; Mužík J; Malúšková D; Májek O; Pavlík T; Koptíková J; Gregor J; Brabec P; Abrahámová J
Klin Onkol; 2014; 27 Suppl 2():19-39. PubMed ID: 25494887
[TBL] [Abstract][Full Text] [Related]
38. Colorectal cancer screening and surveillance: a survey among Thai general surgeons.
Lohsiriwat V; Lohsiriwat D; Thavichaigarn P;
Asian Pac J Cancer Prev; 2009; 10(3):467-70. PubMed ID: 19640193
[TBL] [Abstract][Full Text] [Related]
39. A simulation model for colorectal cancer screening: potential of stool tests with various performance characteristics compared with screening colonoscopy.
Haug U; Brenner H
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):422-8. PubMed ID: 15734968
[TBL] [Abstract][Full Text] [Related]
40. Coverage by examinations associated with early detection of colorectal neoplasia in the Czech Republic.
Ngo O; Hejcmanová K; Suchánek Š; Pehalová L; Dušek L; Zavoral M; Bureš J; Seifert B; Hejduk K; Král N; Májek O
Eur J Public Health; 2023 Jun; 33(3):515-521. PubMed ID: 37141451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
